Predicta Med

Name

Predicta Med

Legal name

Predicta Med Ltd.

Website

https://predicta-med.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Healthcare AI / Clinical Decision Support

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Risk Stratification & Predictive Modeling (utilization, cost, readmission) (HLACAHAB)

akta.pro secondary industries

Diagnostic & Triage Decision Support (HLACAGAA), Clinical & Claims Data Integration for Population Health (payer-provider data fusion) (HLACAHAI), Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA)

Keywords

• Autoimmune disease detection
• Clinical decision support
• EMR chart summarization
• Clinical trial matching
• Healthcare AI software

Headquarters

HQ city

Tel Aviv

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. SaaS/Software Subscription: Cloud-based or on-premise AI platform subscription for healthcare organizations. The company offers standalone primary care software (cloud/on-premise) and EMR integrations via HL7-FHIR protocol, suggesting a per-provider or per-institution subscription model typical of healthcare SaaS.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Predicta Med builds an AI-powered clinical decision support platform for autoimmune specialty care, delivered as cloud-based or on-premise software integrated with electronic medical records via HL7-FHIR. The platform is sold to healthcare organizations and clinicians through enterprise subscriptions and comprises three modules: PredictAI™ for early autoimmune disease detection and workup recommendations, PredictaChart™ for automated patient chart summarization, and PredictaMatch™ for clinical trial matching.

Product overview

Predicta Med offers a unified AI platform for autoimmune specialty care optimization consisting of three integrated modules: PredictAI™ for early detection and risk identification, PredictaChart™ for automated patient chart summarization, and PredictaMatch™ for clinical trial matching. The platform combines advanced clinical algorithms, real-time EMR integration, and specialty-specific intelligence to streamline decision-making and personalize care across the patient journey.

Differentiator

Problem solved

Functional benefit

Products and services

• PredictAI™

Quantifiable outcome

• 10-25% revenue uplift per provider
• +5 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability9 records

Feature10 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• KSM (Kahn Sagol Maccabi)coreStrategic or Co-development PartnerResearch and innovation center of Maccabi Healthcare Services providing 2.5M EMR records and 1.7M claims records for AI model validation and proof of concept across 7 autoimmune disease conditions. KSM leads advanced global health improvements collaborating with scientists, researchers, academic institutions, pharmaceutical companies, startups, and tech companies.
• Maccabi Healthcare ServicescoreStrategic or Co-development PartnerMajor Israeli healthcare organization partnering with Predicta Med for AI-driven autoimmune disease detection and care optimization. Provides clinical data and validation environment for platform development.
• HoagminorStrategic or Co-development PartnerUS health system partner listed in Predicta Med's partner section, representing potential market access and clinical validation partnership in the US healthcare market.
• Stanford MedicinecoreStrategic or Co-development PartnerMedical advisors from Stanford Medicine collaborate with Predicta Med, providing clinical expertise and validation for AI platform development in autoimmune disease care.
• Mayo CliniccoreStrategic or Co-development PartnerMedical advisors from Mayo Clinic (including Dr. Sunanda V. Kane, Professor of Medicine) collaborate with Predicta Med, providing clinical expertise and validation for AI platform development.
• Columbia UniversitycoreStrategic or Co-development PartnerAcademic medical center partner providing medical advisor collaboration for Predicta Med's AI platform development and autoimmune disease research.
• UT Southwestern Medical CentercoreStrategic or Co-development PartnerMedical advisors from Southwestern (including Dr. Stanley Cohen, Former Head of ACR) collaborate with Predicta Med on clinical validation and autoimmune disease expertise.
• Sheba Medical CentercoreStrategic or Co-development PartnerLeading Israeli medical center with multiple advisors (Prof. Shomron Ben-Horin, Chief of Gastroenterology; Prof. Yehuda Shoenfeld, Founder of Zabludowicz Center for Autoimmune Diseases; Prof. Ora Shovman) providing clinical expertise, validation, and autoimmune disease research collaboration.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• K Health: AI-enabled consumer and clinical health platform that uses NLP/LLMs on patient data to support diagnosis and triage. Predicta Med's VP Medical Strategy, Dr. Michael Dreyfuss, was previously a medical domain expert at K Health.
• Atropos Health: Provides real-world evidence-driven clinical decision support from EHR data, enabling physicians to query similar patient outcomes. Comparable as a data-and-AI clinical decision support layer integrated into physician workflow.
• Medial EarlySign: Israel-based AI platform that applies machine learning to EHR data to identify patients at risk of undiagnosed or future disease (e.g., cancer, diabetes). Directly comparable to Predicta Med's EMR-driven risk stratification and clinical decision support approach; Predicta Med's CMO Dan Underberger was previously Senior Medical Director there.
• Regard: AI clinical decision support platform that mines EMR data to surface undiagnosed conditions and streamline documentation for hospitals. Highly comparable to Predicta Med on AI-driven EMR analysis for earlier diagnosis and chart summarization.

Emerging players

• Hippocratic AI: LLM-based clinical agents and decision-support tools aimed at healthcare workflows. Comparable on the LLM/agentic AI architecture used in Predicta Med's agentic AI and NLP modules.
• DreaMed Diabetes: AI clinical decision support for chronic disease management, originally diabetes. Comparable as a condition-specific, AI-driven decision-support platform for chronic care, though narrower in clinical area.
• Glass Health: AI clinical decision support tool for physicians that drafts differential diagnoses and treatment plans from patient data. Comparable as an AI copilot for clinical reasoning, though not autoimmune-specialized.

Broad incumbents

• Suki AI: AI voice assistant for clinicians that automates documentation, coding, and chart summarization inside the EMR. Overlaps with PredictaChart™ in chart-summarization use cases but serves all specialties rather than focusing on autoimmune.
• Tempus Labs: Large-scale AI and data platform combining clinical, molecular, and imaging data to support precision-medicine decisions. Comparable as a healthcare AI/data platform, but with a much broader scope (oncology-led) and far greater scale.
• Change Healthcare: Major healthcare data and analytics platform with clinical decision support and risk-stratification capabilities at scale. Predicta Med's CMO previously served as clinical solution executive at Change Healthcare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/predicta-med

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Predicta Med